Cite Filings / NKTR / 0001564590-18-004105
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-K

Annual Report

NEKTAR THERAPEUTICS · Filed 2018-03-01 · Acc 0001564590-18-004105

Documents 1

  • 10-K Annual Report , nktr-10k_20171231.htm

Around this filing

  • 2019-03-01 10-K Annual Report
  • 2018-03-08 4 Director sold 40,000 shares at an average $97.60 ($3,903,914)
  • 2018-03-08 4 SVP & Chief Operating Officer sold 220,144 shares at an average $99.27 ($21,854,265)
  • 2018-03-01 8-K Results of operations
  • 2018-03-01 10-K Annual Report
  • 2018-02-27 SC 13G/A Amended Statement of Ownership
  • 2017-03-01 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading nktr-10k_20171231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…